Concentra Group Parent (CON) vs Henry Schein (HSIC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Concentra Group Parent (CON) has outperformed Henry Schein (HSIC) over the past year, gaining 106.8% versus a gain of 13.8%. Henry Schein is the larger company by market cap ($9.23 billion vs $5.26 billion), about 1.8 times the size, while Concentra Group Parent is growing revenue faster (+13.9% vs +4.0%). On valuation, Henry Schein trades at a lower forward P/E (13.9x vs 22.0x for Concentra Group Parent).
Concentra Group Parent pays a dividend yielding 0.60%, while Henry Schein does not currently pay one. Concentra Group Parent converts more of its revenue into profit, with a net margin of 7.7% versus 3.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CON | HSIC |
|---|---|---|
| Share price | $41.84 | $83.52 |
| Market cap | $5.26B | $9.23B |
| 1-day change | +0.94% | -1.51% |
| YTD return | +112.60% | +10.51% |
| 1-year return | +106.82% | +13.79% |
| 5-year return | — | +13.42% |
| P/E ratio (TTM) | 24.76 | 22.88 |
| Forward P/E | 21.99 | 13.91 |
| EPS (TTM) | $1.69 | $3.65 |
| Dividend yield | 0.60% | 0.00% |
| Annual dividend | $0.25 | $0.00 |
| Revenue (latest FY) | $2.16B | $13.18B |
| Revenue growth (YoY) | +13.85% | +4.03% |
| Net income (latest FY) | $166.41M | $398.00M |
| Gross margin | 28.34% | 31.14% |
| Operating margin | 15.44% | 4.95% |
| Net margin | 7.69% | 3.02% |
| 52-week high | $44.22 | $92.18 |
| 52-week low | $19.05 | $68.70 |
| Distance from 52-week high | -5.38% | -9.39% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +11.62% | +15.98% |
| Average volume | 1.05M | 1.33M |
| Shares outstanding | 125.72M | 110.54M |
| Employees | 9,967 | 25,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CON has outperformed HSIC by 93.0 percentage points over the past year.
- Concentra Group Parent grew revenue faster in its latest fiscal year (+13.85% vs +4.03%).
About Concentra Group Parent
CON stock →Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
Health Care · Medical Specialities · 9,967 employees
About Henry Schein
HSIC stock →Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide.
Health Care · Medical Specialities · 25,000 employees
CON vs HSIC FAQ
Which is bigger, Concentra Group Parent or Henry Schein?
Henry Schein (HSIC) is larger, with a market capitalization of $9.23B compared with $5.26B for Concentra Group Parent (CON).
Which stock has performed better over the past year, CON or HSIC?
CON returned +106.82% over the past 12 months, compared with +13.79% for HSIC (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CON or HSIC?
HSIC has the lower trailing P/E at 22.9, versus 24.8 for CON. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Concentra Group Parent or Henry Schein?
Concentra Group Parent pays a dividend yielding 0.60%, while Henry Schein does not currently pay a regular dividend.
Are Concentra Group Parent and Henry Schein in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.